Good morning! Katalin Karikó is currently opening the 2nd conference day at the #mRNAHealthConference 2021 with a keynote lecture on the history of mRNA development for therapy. Outstanding woman and fascinating topic, please join us online & in Berlin!
We are pleased to start with the second session of today covering the topic of #Delivery. Follow eight different talks & presentations from industry and academic representatives who are well-known in the field and presenting highly interesting insights.
2020 marked a breakthrough for #mRNA technology with the approval of the 1st mRNA-based vaccine. Now, we are starting with Session I about #mRNA Vaccine Products and Product Candidates. Listen to three interesting talks from @CureVacRNA, @Moderna_tx and @Biontech_Group.
📅 Join live on June 14th the 10th International Cancer Cluster Showcase to learn more on our French oncology selected companies @OSEIMMUNO & @divincell supported by @MATWIN_Bdx !!
📣 To connect, REGISTER: https://t.co/uZWaccGlXM
#cancer#innovation#ICCS21#BIODigital
L'avenir s'écrit en @Occitanie❗
Decouvrez les lauréat-e-s des #InnOvations, notre concours régional qui récompense les entreprises les ➕ innovantes.
Des entreprises pépites à impact positif, qui vous rendront fiers du #MadeInOccitanie !
👉👉https://t.co/BRZMeon8bl
@divincell est récompensé pour DIV'IN : stratégie thérapeutique personnalisée de 1ère classe pour corriger les cellules malades des patients. Une biotechnologie prometteuse pour les traitements du cancer et des maladies génétiques. 🔬#InnOvations2021
https://t.co/M60fNQwf6d
Félicitations à @divincell, lauréat du prix "Produit ou Service du futur de l'année" récompensé par Marianne PEYROT, Déléguée régionale – DRARI ! Bravo à eux 😊
#InnOvations2021
En live 🔴 https://t.co/rdJrEnAZRa
We just announced that the FDA has authorized the Moderna COVID-19 Vaccine in the U.S. for emergency use to prevent COVID-19 in individuals 18 and over. The Moderna COVID-19 Vaccine has not been approved or licensed by the FDA. https://t.co/zyd6dfJr53
En octobre dernier le board @MATWIN_Bdx attribuait à @divincell l'award de « Best therapeutic oncology innovative approach"! Un projet prometteur à suivre avec de possibles applications sur la #COVID19 !
https://t.co/wf9NZlG3uO
Next @DIVINCELL will participate at the Virtual 8th International mRNA Health Conference 2020. We will be presenting our recent results on mRNA delivery
#mrna#cancer#therapeutics#drugdelivery
https://t.co/jabvvA1sOM
We are proud to announce that DIVINCELL therapeutic strategy “DIV-TREX” was awarded as "Best innovative therapeutic approach" by the MATWIN International Board.
We thank @MATWIN_Bdx for their support and excellent coaching.
👏Congrats to the 11 selected applicants and the 3 awarded projects @HEPHAISTOSPhar1@divincell @FastbaseSol by the prestigious @MATWIN_Bdx Board !!
➡️ A unique opportunity to move projects forward and optimize collaboration opportunities!
#WINattitude#cancer#innovation